Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
2
×
startups
arch venture partners
artificial intelligence
azacitidine
beta-thalassemia
bill martin
bio
boston
boston blog main
boston top stories
dacogen
deals
decitabine
dna
drug development
epigenetics
epizyme
executive
farydak
flagship pioneering
fulcrum therapeutics
funding
gv
health
insulated genomic domains
johnson & johnson
julie sunderland
kaleido biosciences
life sciences
machine learning
mahesh karande
managing partner
national blog main
national top stories
neuroscience
new york blog main
new york top stories
omega therapeutics
panobinostat
What
approach
2
×
drugs
therapeutics
2
×
aims
based
betting
biotech
blackthorn
called
challenges
company
create
debuts
developing
disorders
effective
epigenetic
epigenetics
field
finding
flagship’s
gv
health
learning
machine
medicine
medicines
mental
million
morning
neurobehavioral
new
numerous
omega
personalized
pulls
research
startup
step
technological
Language
unset
Current search:
approach
×
biotech
×
therapeutics
×
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@techcrunch.com
4 years ago
Neurobehavioral health company Blackthorn pulls in $76 million from GV to treat mental disorders